Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson's disease

Neurol Sci. 2003 Oct;24(3):157-8. doi: 10.1007/s10072-003-0107-1.

Abstract

We investigated the effects of dopaminergic stimulation on anti-apoptotic protein Bcl-2, pro-apoptotic enzyme caspase- 3, and anti-oxidant/anti-apoptotic enzyme Cu/Zn superoxide dismutase (SOD) in human lymphocytes exposed to dopamine (DA). The same determinations were also carried out in parkinsonian patients treated with L-dopa. Caspase-3 activity and Cu/Zn SOD levels tended to increase when lymphocytes were exposed to low or intermediate doses of DA, while a decrease was observed, particularly in caspase-3 activity, with the higher DA dose. Bcl-2 levels were unaffected. In patients, we observed a negative correlation between Cu/Zn SOD levels and daily intake of L-dopa, which also tended to be negatively correlated with caspase-3 activity, but not with Bcl- 2. Our results show that dopaminergic stimulation is associated with complex changes in regulatory proteins of apoptosis.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Apoptosis / drug effects*
  • Cardiotonic Agents
  • Case-Control Studies
  • Caspase 3
  • Caspases / metabolism
  • Dopamine / pharmacology*
  • Dopamine Agents / therapeutic use
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • In Vitro Techniques
  • Levodopa / therapeutic use
  • Lymphocytes / drug effects*
  • Lymphocytes / metabolism
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy
  • Parkinson Disease / metabolism*
  • Parkinson Disease / physiopathology
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Superoxide Dismutase / metabolism

Substances

  • Cardiotonic Agents
  • Dopamine Agents
  • Proto-Oncogene Proteins c-bcl-2
  • Levodopa
  • Superoxide Dismutase
  • CASP3 protein, human
  • Caspase 3
  • Caspases
  • Dopamine